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ABSTRACT
Background and Objective: The data on the obstetric 
and gynecological complications in patients diagnosed with 
neuromuscular diseases is very limited and is primarily 
obtained from various case reports, series, and small stud-
ies. The objective of our study was to analyze prevalence of 
these complications in a large cohort of patients with vari-
ous neuromuscular diseases. 
Methods: This study is a retrospective chart review of pa-
tients diagnosed with various neuromuscular diseases at 
the University of Missouri, Columbia, from 2012 to 2017. 
We included patients who have at least one year follow up 
with us. We collected data on patient demographics, neuro-
muscular disease diagnosed, obstetric complications, and 
gynecologic complications. Data are reported as means ± 
SEM, and the results reported using prevalence rates.
Results: Ninety-five female patients were identified. 
Among them, 97% were Caucasian, and 3% were African-
American with a mean age of 47.96 years. Neuromuscular 
diseases identified among them are Myasthenia Gravis 
(44%), Muscular Dystrophy (23%), Amyotrophic Lateral 
Sclerosis-ALS (16%), Charcot-Marie-Tooth disease-CMT 
(10%), and Spinal Muscular atrophy- SMA (7%). The ma-
jority of the patients reviewed have had no obstetric com-
plications- (89.40%). The most common obstetric compli-
cation recorded was C-section (8.40%). 41% of women did 
not have any gynecological complaints. Urine incontinence 
(24.20%) is the most common complication. 
Conclusion: C-sections and urinary incontinence are com-
mon obstetric and gynecological events seen in women with 
neuromuscular disease. 
Keywords: Obstetric events in NMD, Neuromuscular dis-
eases, Myasthenia Gravis, Spinal muscular atrophy, Char-
cot-Marie-Tooth disease, Muscular dystrophies.
Introduction
The data on obstetric and gynecological complications 
in patients with neuromuscular diseases (NMD) is limited 
and is primarily obtained from various case reports, case se-
ries, and small studies.1-2 Previous studies have found that 
neuromuscular disorders, although debilitating, generally 
have a favorable outcome in pregnancy1-3 yet data on ante-
natal, perinatal periods are lacking. Further gynecological 
complications are not commonly reported in these studies. 
With newer treatments and improved supportive care, many 
patients are living longer and deciding to have families and 
neuromuscular physicians are commonly asked to provide 
guidance during obstetric and gynecological events.2 In our 
study, we report both gynecological and obstetric histories 
of 95 patients diagnosed with various neuromuscular dis-
eases (NMD), i.e., Myasthenia gravis, Myotonic Dystrophy, 
ALS, Spinal Muscular atrophy, and Charcot-Marie-Tooth 
disease. 
Methods
This is a retrospective chart review of patients diag-
nosed with various neuromuscular diseases at the Univer-
sity of Missouri, Columbia, from 2012 to 2017. We reviewed 
the clinic notes from the neurology, obstetrics and gynecol-
ogy, family medicine, internal medicine clinic visits for each 
patient. We included patients who have at least one year fol-
low up with us and seen atleast one of the specialists listed 
above.
We collected data on patient demographics, neuromus-
cular disease diagnosed, obstetric complications, and gyne-
cologic complications. Data are reported as means ± SEM, 
and the results reported using prevalence rates. This study 
was approved by the Institutional Review Board (IRB) at 
the University of Missouri, Columbia, MO.
 
Results
Ninety-five female patients were identified. Among 
them, 97% were Caucasian, and 3% were African-American 
with a mean age of 47.96 (+/-10.2 years) years as depicted 
in table 1. 
Table 1: Patient demographics
Number of patients N=95
Mean age 47.96 (+/-10.2)years
Race Caucasian- 97%African-American- 3%
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 Neuromuscular diseases identified among them are 
Myasthenia Gravis (44%), Muscular Dystrophy (23%), 
Amyotrophic Lateral Sclerosis-ALS (16%), Charcot-Ma-
rie-Tooth disease-CMT (10%), and Spinal Muscular atro-
phy- SMA (7%) as shown in figure 1.
The majority of the patients reviewed had no obstetric 
complications- (89.40%). In our study group, 40 got preg-
nant, and the number of pregnancy events recorded was 98. 
The most common obstetric complication recorded was C-
section (8.40%). Other complications recorded were pro-
longed labor (1.10%) and Placenta Previa (1.10%). Among 
the study group, patients diagnosed with SMA and CMT, 
not a single obstetric complication was recorded. Women 
diagnosed with Myasthenia Gravis reported having the 
highest obstetric complications among all the neuromus-
cular diseases reported. 41% of women did not have any 
gynecological complaints. Urine incontinence (24.20%) is 
the most common complication, post-menopausal bleeding 
(2.10%). Other complications were ovarian cysts (8.40%), 
recurrent UTIs (8.40%), pelvic pain (7.40%), endometrio-
sis (5.30%), Polycystic ovarian syndrome (PCOS-3.20%). 
Women diagnosed with Myasthenia Gravis reported hav-
ing the highest obstetric complications among all the neu-
romuscular diseases reported. The distributions of the ob-
stetric and Gynecological complications, evaluated among 
the study population are depicted in the figures 2 and 3 re-
spectively. 
Discussion
The multi-disciplinary team must take into account 
managing women considering to become pregnant.3,6 MG 
is an auto-immune disorder affecting the women of repro-
ductive age twice more than men.5 Myasthenia neither has 
any effect on fertility, and it is not uncommon to witness 
patients who are pregnant, nor does the pregnancy have 
any effects on the disease course.2,5 However, the disease 
exacerbations are seen mostly in the first trimester and 
post-partum.3,5-6 In a retrospective evaluation of pregnant 
women with myasthenia, the rate of C-section was as high 
as 78.3%. The rate of C-section in our study is 8.40% for all 
the NMDs combined. Although C-section is necessitated, 
vaginal deliveries are considered safe in the absence of any 
myasthenia crisis.6 
Muscular dystrophies (MD) are a rare set of genetical-
ly inherited diseases, characterized by muscular weakness 
and wasting.7 In prior surveys, complications like pre-term 
labor, placenta previa, and others are reported in myotonic 
dystrophy type 1. Also, these women have a higher rate of 
urinary tract infections.8 In our study, the rate of placenta 
previa reported was 1.10%. 
ALS is uncommon in women of reproductive age, and 
the association of the disease reported through few case 
Figure 1. Distribution of the types of neuromuscular diseases 
evaluated. MG-Myasthenia Gravis, MD-Muscular Dystro-
phies, ALS-Amyotrophic Lateral Sclerosis, CMT- Charcot-
Marie-Tooth disease, and SMA- Spinal Muscular atrophy.
Figure 2. Distribution of the types of OB complications eval-
uated among women with a neuromuscular disease.
Figure 3. Distribution of the types of GYN complications 
evaluated among women with a neuromuscular disease.
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reports is purely coincidental.3 We lack data, that would 
clearly state to limit maternal survival.3
CMT is the most common hereditary motor and sen-
sory neuropathies. It is reported through the case reports 
that pregnancy does not contribute to disease severity9 and 
the outcome of pregnancy in these patients is promising 
with complications not higher than the normal population.10 
In our study, 10% of the patients diagnosed with CMT and 
as mentioned majority patients reviewed had no obstetric 
complications (89.40%). 
Spinal muscular atrophy is an autosomal recessive neu-
rodegenerative disease characterized by progressive loss of 
anterior horn neurons.11 7% of our study patients diagnosed 
with SMA and none of them were reported to have any ob-
stetric complication. Although subtype I is fatal, Subtypes 
II, III & IV may consider pregnancy as they reach the re-
productive age.11 There is no evidence that it affects fertil-
ity, and the pregnancy outcomes are at par with the normal 
population, giving a positive outlook for those who consider 
becoming pregnant.11 Although there are risks, the multidis-
ciplinary approach to evaluate each case is strongly recom-
mended.11
The data on the association of gynecological complica-
tions and neuromuscular disease is not well established. In 
our study, the most common complication is urinary incon-
tinence in the study patients. In a retrospective study, it was 
reported that patients with inherited neuromuscular dis-
eases (Muscular dystrophies and Spinal muscular atrophy) 
develop urinary tract symptoms.12 The most common pre-
senting complaint was urinary incontinence in this study, as 
seen in our study group.12
Besides these, additional studies are imperative to set 
the appropriate guidelines for the management of pregnan-
cy and address reproductive health issues in them. The ad-
dition of OBGYN physicians to the multidisciplinary neu-
romuscular disease clinics, where these patients are getting 
treated can be considered as the survival and quality of life 
improve in many of our neuromuscular patients.
The limitations of our study are, not all the patients 
in our study cohort were assessed by the neuromuscular 
physician during pregnancy. Also, since there is no control 
group, it is hard to say that the complications recorded in 
our study group are about the same as the rest of the popu-
lation. The other limitation is we included only women in 
our study, as our objective is to describe the obstetric and 
gynecological complications.
Conclusion
C-sections and urinary incontinence are common ob-
stetric and gynecological events seen in women with neuro-
muscular disease
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